Fortress Biotech Inc

NASDAQ:FBIO  
0.65
-0.01 (-1.51%)
7:26:45 PM EDT: $0.67 +0.01 (+2.10%)
Earnings Announcements

Fortress Biotech Reports Third Quarter 2022 Financial Results, Recent Corporate Highlights

Published: 11/14/2022 21:53 GMT
Fortress Biotech Inc (FBIO) - Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights.
Q3 Revenue $16.1 Million Versus $19.6 Million.
Qtrly Loss per Share $0.25.
Qtrly Non-GAAP Loss per Share $0.08.
Q3 Earnings per Share View $-0.27, Revenue View $20.8 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $23.19 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $22.85 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.